# The efficacy and safety of apremilast, etanercept and placebo in patients with moderate‐to‐severe plaque psoriasis: 52‐week results from a phase IIIb, randomized, placebo‐controlled trial (LIBERATE)

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/the-efficacy-and-safety-of-apremilast-etanercept-and-placebo-in-patients-with/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Kristian Reich,Melinda Gooderham,L. Green,Anthony Bewley,Z. Zhang,Irina Khanskaya,Robert M. Day,Joana Gonçalves,K. Shah,Vincent Piguet,Jennifer Soung |
| Citations | 200 |
| DOI | 10.1111/jdv.14015 |
| Fields | Biochemistry, Genetics and Molecular Biology,Immunology and Microbiology |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jdv.14015 |
| OpenAlex ID | https://openalex.org/W2532238474 |
| PMID | 27768242 |
| Type | article |
| Year | 2016 |

## Paper authors

- [Anthony Bewley](https://scholariq.org/researchers/anthony-bewley/)
- [Melinda Gooderham](https://scholariq.org/researchers/melinda-gooderham/)

## Paper journal

- [Journal of the European Academy of Dermatology and Venereology](https://scholariq.org/journals/journal-of-the-european-academy-of-dermatology-and-venereology/)

## Paper primary topic

- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)

## Paper topics

- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)
- [Phosphodiesterase function and regulation](https://scholariq.org/topics/phosphodiesterase-function-and-regulation/)
- [Adenosine and Purinergic Signaling](https://scholariq.org/topics/adenosine-and-purinergic-signaling/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.